Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
Ontario Votes 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by AVEO Oncology
AVEO Oncology Announces Appointment of Jeb Ledell as Chief Operating Officer
December 01, 2021
From
AVEO Oncology
Via
Business Wire
Tickers
AVEO
AVEO Oncology Announces Participation at Two Upcoming Virtual Investor Conferences
November 10, 2021
From
AVEO Oncology
Via
Business Wire
Tickers
AVEO
AVEO Oncology Reports Third Quarter 2021 Financial Results and Provides Business Update
November 08, 2021
From
AVEO Oncology
Via
Business Wire
Tickers
AVEO
AVEO Oncology to Announce Third Quarter 2021 Financial Results and Host Conference Call and Webcast on November 8, 2021
November 01, 2021
From
AVEO Oncology
Via
Business Wire
Tickers
AVEO
AVEO Oncology Announces Ficlatuzumab Granted Fast Track Designation by the U.S. FDA for the Treatment of Relapsed or Recurrent Head and Neck Squamous Cell Carcinoma
September 20, 2021
From
AVEO Oncology
Via
Business Wire
Tickers
AVEO
AVEO Oncology Announces Participation at Two Upcoming Virtual Investor Conferences
August 30, 2021
From
AVEO Oncology
Via
Business Wire
Tickers
AVEO
AVEO Oncology Reports Second Quarter 2021 Financial Results and Provides Business Update
August 05, 2021
From
AVEO Oncology
Via
Business Wire
Tickers
AVEO
AVEO Oncology to Announce Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 5, 2021
July 29, 2021
From
AVEO Oncology
Via
Business Wire
Tickers
AVEO
AVEO Oncology to Host Key Opinion Leader Webinar on FOTIVDA® (tivozanib) for Relapsed or Refractory Renal Cell Carcinoma
July 08, 2021
From
AVEO Oncology
Via
Business Wire
Tickers
AVEO
AVEO Oncology to Host Key Opinion Leader Webinar on Ficlatuzumab in Head and Neck Squamous Cell Carcinoma
June 07, 2021
From
AVEO Oncology
Via
Business Wire
Tickers
AVEO
AVEO Oncology to Present at the Jefferies 2021 Virtual Healthcare Conference
May 25, 2021
From
AVEO Oncology
Via
Business Wire
Tickers
AVEO
AVEO Oncology Announces Presentation of Long-Term Efficacy Follow Up, Additional Tolerability Data from the Phase 3 TIVO-3 Study of FOTIVDA® (tivozanib) in Relapsed or Refractory Renal Cell Carcinoma
May 19, 2021
From
AVEO Oncology
Via
Business Wire
Tickers
AVEO
AVEO Oncology Announces Positive Results from Randomized Phase 2 Study of Ficlatuzumab in Combination with Cetuximab in Pan-Refractory, Metastatic HNSCC
May 19, 2021
From
AVEO Oncology
Via
Business Wire
Tickers
AVEO
AVEO Oncology Reports First Quarter 2021 Financial Results and Provides Business Update
May 10, 2021
From
AVEO Oncology
Via
Business Wire
Tickers
AVEO
AVEO Announces Appointment of Kevin Cullen, M.D., to Its Board of Directors
April 16, 2021
From
AVEO Oncology
Via
Business Wire
Tickers
AVEO
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.